FLORHAM PARK, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal ...
VOQUEZNA, the first and only FDA-approved potassium-competitive acid blocker (PCAB), is now available through major retail pharmacies and BlinkRx, an end-to-end digital fulfillment channel VOQUEZNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results